Skip to content
Compare stocks

Sanara MedTech vs Kestra Medical Technologies vs STAAR Surgical

Score, categories, valuation, dividend, crash risk and price performance of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical side by side. Figures from the overnight run, closing prices from 19 Nov 2026.

Key figures compared

SMTISanara MedTechKMTSKestra Medical TechnologiesSTAASTAAR Surgical
MEQIRI Score
Score613944
Fundamentals391740
Growth705045
Profitability871733
Valuation48no data29
Technical analysis766363
Momentum876447
Stability295271
Capital allocation452530
Price and valuation
Closing price$32.67$26.63$25.03
Market cap$300M$1.59B$1.26B
P/ELossLoss2,429.8
Forward P/Eno dataLoss expected45.0
Fair value$36.27no data$18.05
Fair value versus price+11.0%no data−27.9%
Growth and dividend
Revenue growth per year+45.9%no data+11.7%
Dividend yield0.0%0.0%0.0%
Risk and performance
Crash riskhigh36 in 100no datahigh36 in 100
Price 1 year+71.4%+3.1%−5.4%
Price 5 years+4.3%no data−77.3%
IndustryMedical (Instruments & Supplies)Medical (Instruments & Supplies)Medical (Instruments & Supplies)

Score and figures from the overnight run, closing prices from 19 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.

Price performance

  • Sanara MedTech
  • Kestra Medical Technologies
  • STAAR Surgical

All lines start at 100 on 6 March 2025, the first trading day of the youngest stock. Closing prices without dividends, each stock in its trading currency.

Questions and Answers

How do Sanara MedTech, Kestra Medical Technologies and STAAR Surgical compare on the MEQIRI Score?

The MEQIRI Score (0 to 100) is 61 for Sanara MedTech, 39 for Kestra Medical Technologies and 44 for STAAR Surgical. The category Profitability differs most, with 87 for Sanara MedTech, 17 for Kestra Medical Technologies and 33 for STAAR Surgical. The score combines eight categories and is recalculated every night.

What is the P/E ratio of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?

Sanara MedTech: P/E Loss, forward P/E no data. Kestra Medical Technologies: P/E Loss, forward P/E Loss expected. STAAR Surgical: P/E 2,429.8, forward P/E 45.0. As of the close on 19 Nov 2026.

What is the dividend yield of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?

Sanara MedTech: 0.0%. Kestra Medical Technologies: 0.0%. STAAR Surgical: 0.0%. Based on payments over the last twelve months.

What is the crash risk of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?

Sanara MedTech: Crash risk high (36 in 100). Kestra Medical Technologies: no data. STAAR Surgical: Crash risk high (36 in 100). Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.

Why does the price chart start at 100?

All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.

Does the comparison tell me which stock to buy?

No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.

More comparisons

Compare stocks